Antibodies for molecular imaging of vulnerable plaques in atherosclerosis
US9782501B2 · kind B2 · utility
0Cited by
0References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 15, 2012 |
| Grant date | Oct 10, 2017 |
| Priority date | — |
| Expiry date | Oct 14, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies for molecular imaging of vulnerable plaques in atherosclerosis Antibody specifically binding to atherosclerosis lesions for in vivo imaging and methods for in vivo imaging of atherosclerosis lesions in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.